Johnson & Johnson (NYSE: JNJ) has announced the acquisition of Shockwave Medical, Inc. (Nasdaq: SWAV) for a staggering $335.00 per share in cash, totaling an enterprise value of approximately $13.1 billion, inclusive of cash acquired. This definitive agreement, approved by both companies’ boards of directors, marks a significant expansion of Johnson & Johnson MedTech’s footprint…
Tag: Johnson & Johnson MedTech
Johnson & Johnson MedTech acquires Laminar Inc. for an upfront $400 million
NEW BRUNSWICK: Johnson & Johnson MedTech, a division of Johnson & Johnson that focuses on medical intervention solutions, announced today that it has completed the acquisition of Laminar Inc., a privately-held medical device company that specializes in eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib). The deal was worth $400…